Paper Details

  1. Home
  2. Paper Details

Treatment of chronic migraine with intramuscular pericranial injections of onabotulinumtoxin a.

Author: BelvisRobert, MasNatalia

Clinical Trial, Phase IIIA Phase III trial is a trial that further rigorously verifies the efficacy and safety of a new drug or treatment, whose efficacy and safety have been confirmed in a Phase II trial, in a large number of patients, and evaluates whether it is superior to existing treatments.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Chronic migraine is the most common and disabling type of migraine. Topiramate and injections of onabotulinumtoxin A (Botox) are the only treatments specifically studied for chronic migraine and are considered effective. Botox injections, particularly around the head and neck, have shown good effectiveness and safety in reducing headache days, migraine frequency, and medication use, while improving quality of life. Botox is a viable treatment option for chronic migraine, similar to topiramate.
Paper Details　
Original Abstract of the Article :
Chronic migraine is the most frequent and disabling complication of migraine. To date, only two drugs have been specifically analysed for the treatment of chronic migraine, topiramate and onabotulinumtoxin A, and in the evidence-based medicine categories, they have achieved level of evidence I and a...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.2174/1574889810666150131124603

データ提供：米国国立医学図書館（NLM）

Onabotulinumtoxin A: A Promising Treatment for Chronic Migraine

Migraine headaches, like a persistent desert wind, can cause debilitating pain and disruption to daily life. This study focuses on chronic migraine, a particularly challenging form of this disorder, and examines the effectiveness of onabotulinumtoxin A, a drug that blocks nerve signals, in managing this condition.

Relief from the Migraine Desert: Onabotulinumtoxin A's Efficacy

The researchers investigated the efficacy and safety of onabotulinumtoxin A injections in patients with chronic migraine. This is akin to a traveler seeking respite from the harsh desert conditions by seeking shelter in a hidden oasis. The results of the study show that onabotulinumtoxin A injections can significantly reduce the number of headache days, improve quality of life, and decrease the need for other medications.

A Valuable Treatment Option: Onabotulinumtoxin A's Role

The study concludes that onabotulinumtoxin A injections offer a viable treatment option for chronic migraine, comparable in efficacy to topiramate, a commonly prescribed anti-seizure medication used for migraine prevention. This is like discovering a new and effective method for navigating the desert, offering a safe and reliable route to reach a desired destination.

Dr. Camel's Conclusion

The study offers hope for those struggling with chronic migraine. Onabotulinumtoxin A injections provide a promising treatment option for reducing headache frequency, improving quality of life, and potentially alleviating the burden of this debilitating condition. As with any medical treatment, it is important to consult with a healthcare professional to determine if onabotulinumtoxin A is right for you.
Date :
  1. Date Completed 2015-11-06
  2. Date Revised 2019-11-13
Further Info :

Pubmed ID

25643127

DOI: Digital Object Identifier

10.2174/1574889810666150131124603

Related Literature

Article Analysis
・Effective treatment of migraine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.